Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Hepatitis

Free Subscription 09.10.2023 2 AIDS 1 BMC Cancer 1 BMC Gastroenterol 1 Eur J Gastroenterol Hepatol 1 Gastroenterology 1 Gut 1 J Hepatol 1 J Immunol 1 J Infect Dis 2 J Med Virol 3 J Viral Hepat 3 J Virol 1 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. GANDHI MM, Nguyen KL, Lake JE, Liao D, et al
   Proprotein convertase subtisilin/kexin 9 (PCSK9) levels decline with HCV therapy in people with HIV/HCV and correlate with inflammation.
   AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003739.
   PubMed         Abstract available
   
   
2. MUULA GK, Bosomprah S, Sinkala E, Nsokolo B, et al
   HBV viral replication markers and hepatic fibrosis in untreated chronic HBV infection with and without HIV coinfection in Zambia.
   AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003659.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. BARAKA K, Abozahra RR, Badr E, Abdelhamid SM, et al
   Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC.
   BMC Cancer. 2023;23:938.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. TU H, Liu R, Zhang A, Yang S, et al
   Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis.
   BMC Gastroenterol. 2023;23:342.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

5. TSAI PS, Cheng YM, Wang CC, Kao JH, et al
   The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
   Eur J Gastroenterol Hepatol. 2023;35:1278-1283.
   PubMed         Abstract available
   
   

   
   Gastroenterology

6. DARA L, Ghabril M, Phillips E, Kleiner D, et al
   A 68-year-old woman with unexplained liver enzyme elevation and active chronic hepatitis: Beware of drug induced autoimmune like hepatitis.
   Gastroenterology. 2023 Oct 3:S0016-5085(23)05078.
   PubMed        
   
   

   
   Gut

7. LIU Z, Lin C, Mao X, Guo C, et al
   Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people.
   Gut. 2023 Oct 5:gutjnl-2023-330691. doi: 10.1136/gutjnl-2023-330691.
   PubMed         Abstract available
   
   

   
   J Hepatol

8. LU W
   A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!
   J Hepatol. 2023 Oct 3:S0168-8278(23)05142-5. doi: 10.1016/j.jhep.2023.
   PubMed        
   
   

   
   J Immunol

9. KANAI K, Kageyama S, Yoshie O
   Involvement of TLR4 in Acute Hepatitis Associated with Airway Infection of Murine gamma-Herpesvirus 68.
   J Immunol. 2023 Sep 29:ji2200653. doi: 10.4049/jimmunol.2200653.
   PubMed         Abstract available
   
   

   
   J Infect Dis

10. FALADE-NWULIA O, Lesko CR, Fojo AT, Keruly JC, et al
    Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity.
    J Infect Dis. 2023 Oct 5:jiad433. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

11. WU WJ, Lin CL, Liu CJ, Huang YW, et al
    Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
    J Med Virol. 2023;95:e29138.
    PubMed         Abstract available
    
    
12. FU MX, Simmonds P, Andreani J, Baklan H, et al
    Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors.
    J Med Virol. 2023;95:e29144.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

13. VANWOLLEGHEM T, Armstrong PA, Buti M, FitzSimons D, et al
    The elimination of hepatitis D as a public health problem: Needs and challenges.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13891.
    PubMed         Abstract available
    
    
14. VIRTUDAZO MCC, Aquino JB, Arellano RNB, Fortes RA, et al
    The role of dried blood spot tests in the detection of hepatitis B infection: A systematic review.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13890.
    PubMed         Abstract available
    
    
15. BEGHIN J, Meier-Stephenson V
    Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature.
    J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13889.
    PubMed         Abstract available
    
    

    
    J Virol

16. LI Y, Yang Y, Li T, Wang Z, et al
    Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
    J Virol. 2023 Oct 3:e0109023. doi: 10.1128/jvi.01090.
    PubMed         Abstract available
    
    
17. NEPAL S, Holmstrom ED
    Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein.
    J Virol. 2023 Sep 29:e0089223. doi: 10.1128/jvi.00892.
    PubMed         Abstract available
    
    
18. XU L, Paine AC, Barbeau DJ, Alencastro F, et al
    Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    J Virol. 2023;97:e0085323.
    PubMed         Abstract available
    
    

    
    PLoS One

19. ZHANG Z, Liang G, Chang K
    Stationary distribution of a reaction-diffusion hepatitis B virus infection model driven by the Ornstein-Uhlenbeck process.
    PLoS One. 2023;18:e0292073.
    PubMed         Abstract available
    
    

    
    Vaccine

20. SUSARLA SK, Gupta M, Uttam KG, Palkar S, et al
    Immunogenicity and safety of Havisure(TM) vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.
    Vaccine. 2023 Sep 1:S0264-410X(23)01050-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.